Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-056838

President and CEO sold 43,620 shares at an average $65.05 ($2,837,333)

  • President and CEO acquired 43,620 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meeker David P President and CEO 2025-06-03 Option exercise 10b5-1 +43,620 $4.59 $200,216 245,445 D
Meeker David P President and CEO 2025-06-03 Sale 10b5-1 −43,346 $65.04 $2,819,358 202,099 D
Meeker David P President and CEO 2025-06-03 Sale 10b5-1 −274 $65.60 $17,975 201,825 D
Derivatives
Meeker David P President and CEO 2025-06-03 Option exercise · Stock Option (Right to Buy) 10b5-1 −43,620 0 D
Open-market sales · 43,620 sh · avg $65.05 · $2,837,333
Loading xslF345X05/tm2517215-1_4seq1.xml…